Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.
about
Human immunodeficiency virus type 2 Gag interacts specifically with PRP4, a serine-threonine kinase, and inhibits phosphorylation of splicing factor SF2Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virionsInvolvement of a small GTP binding protein in HIV-1 release.HIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchStructural analysis of viral infectivity factor of HIV type 1 and its interaction with A3G, EloC and EloBParadigm development: comparative and predictive 3D modeling of HIV-1 Virion Infectivity Factor (Vif).ERK1/2-mediated phosphorylation of small hepatitis delta antigen at serine 177 enhances hepatitis delta virus antigenomic RNA replicationThe inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain.Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1.Mass spectrometry analysis of HIV-1 Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity.Baculovirus display of single chain antibody (scFv) using a novel signal peptideCellular and viral specificities of human immunodeficiency virus type 1 vif protein.Human immunodeficiency virus and AIDS: insights from animal lentivirusesIdentification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded VifVif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.Characterization of RNA binding and chaperoning activities of HIV-1 Vif protein. Importance of the C-terminal unstructured tail.Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function.HIV-1 Vif inhibits G to A hypermutations catalyzed by virus-encapsidated APOBEC3G to maintain HIV-1 infectivityHuman immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection.Amino acid residues 88 and 89 in the central hydrophilic region of human immunodeficiency virus type 1 Vif are critical for viral infectivity by enhancing the steady-state expression of Vif.Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription.Characterization of staufen1 ribonucleoproteins by mass spectrometry and biochemical analyses reveal the presence of diverse host proteins associated with human immunodeficiency virus type 1.Peptide inhibitors of HIV-1 protease and viral infection of peripheral blood lymphocytes based on HIV-1 Vif.APOBEC3G impairs the multimerization of the HIV-1 Vif protein in living cells.Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.Vif is an auxiliary factor of the HIV-1 reverse transcriptase and facilitates abasic site bypass.Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions.DNA repair enzyme uracil DNA glycosylase is specifically incorporated into human immunodeficiency virus type 1 viral particles through a Vpr-independent mechanism.Vif and the p55(Gag) polyprotein of human immunodeficiency virus type 1 are present in colocalizing membrane-free cytoplasmic complexes.Mutational analysis of the human immunodeficiency virus type 1 Vif protein.Roles of Pr55(gag) and NCp7 in tRNA(3)(Lys) genomic placement and the initiation step of reverse transcription in human immunodeficiency virus type 1.Role of Vif in stability of the human immunodeficiency virus type 1 coreHuman immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging processNucleocapsid mutations turn HIV-1 into a DNA-containing virus.Functional analysis of Vif protein shows less restriction of human immunodeficiency virus type 2 by APOBEC3G.Requirements for nucleocapsid-mediated regulation of reverse transcription during the late steps of HIV-1 assembly.Simultaneous mutations in CA and Vif of Maedi-Visna virus cause attenuated replication in macrophages and reduced infectivity in vivo.
P2860
Q24305530-A4B4AF57-2470-435A-B6AE-AEC23AE72E81Q24678970-798B9C44-68A9-4416-9B8E-8EBBBF03B0D4Q24815862-6C6192F5-F755-47D7-B833-308E1F7F80DCQ26746070-D5B3D373-CED3-4A85-8C4A-1147F5FEEBA6Q28540150-2CBE0E05-3EEC-4990-A1B6-A29456AD2A4AQ30362641-48DDA86F-797D-421B-ACAC-753807CF93C3Q30439951-8A24152A-AA39-4C88-953E-79653C21583AQ30440445-C0F0951F-23A4-4D54-A8B8-6D878222DA54Q30860339-D6B6DE03-4054-40DD-BD05-589B85204E34Q33289183-42DF0FE1-41F2-4EA5-86DA-702F22848A57Q33751786-BDA27C95-721F-482F-9DF5-B2511E4B0C50Q33806688-57916D78-F915-4E42-8F1C-A19964F7CDCCQ33809273-D68B2326-3DD1-4B98-B07F-DC91D6295BD3Q33826857-1511D41E-A5EF-406B-8A1E-78227FE16D77Q33841920-6D3404A5-C599-42FB-AF2F-91571C11A656Q33852465-3A312931-1934-41A9-8CC4-676109952F1CQ34266485-15F3C7EB-23FA-48A5-A049-4972706484AFQ34312616-8E4AE882-CA3C-4D07-A6BE-179A0F451D42Q34345408-F64E8C25-C96F-471C-975B-618B793F0EEEQ34354834-BD712A65-6D69-4193-A027-AB487487903DQ34465108-36C29BED-409A-46F3-8AA3-D357DCBAD47DQ34465355-2E29D216-23CA-4558-A7D0-4485E4DA03ACQ35990905-FB44239E-82AD-41DE-B603-A0FEAE086376Q36364322-243A837C-35A0-4572-94FB-F63062148CBDQ36805150-A00DDADF-A2BF-411E-8E8F-789D0C6F1369Q36827236-FE6033F4-F89D-4B78-A1D3-8613CC5868CCQ36959125-88696BDE-0585-4AC7-BDC5-3B458C56766BQ37504507-480956FA-AA96-49DF-A561-CA52479DF13FQ38337622-2F247EF9-9A0D-4055-8C52-846E2216E813Q39549465-B5309C1D-BF91-4AA5-B49B-085C28D543F9Q39549602-0EB83364-BE82-4BF2-A79B-BED8696E9FE3Q39549710-C890B32C-0D35-46CD-A6D1-9EEC1450896DQ39549716-4CD48542-709B-4FDA-9DD5-463C22BBE798Q39585566-8799BCD9-BAB5-44B6-B486-BF3B10E49556Q39597709-3E3812F6-4CDD-4E60-802D-AB5DB93CB622Q39612144-7535C348-86E3-43E8-9817-65B521B38F74Q40009476-14C2514C-0687-461B-94BA-F56F9674F769Q40478201-282C3E7B-F225-457F-A42C-D68A02EB2BDCQ40641640-0CB65F3D-0D14-4F1E-A8F9-9A10AB071425Q40669940-B808F1BF-60B5-4A40-9219-D8941AF2DA8C
P2860
Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.
@ast
Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.
@en
type
label
Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.
@ast
Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.
@en
prefLabel
Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.
@ast
Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.
@en
P2093
P2860
P1433
P1476
Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.
@en
P2093
M Courcoul
P Boulanger
P2860
P304
P407
P577
1997-12-01T00:00:00Z